1.
Using dynamic treatment regimes to understand erythropoietin-stimulating agent hyporesponsiveness
by Pollack, Ari H
Pediatric nephrology (Berlin, West), 2018-04-04, Vol.33 (8), p.1411-1417
2.
Prevalence of hypogonadism in male patients with renal failure
by Albaaj, F
Postgraduate medical journal, 2006-10, Vol.82 (972), p.693-696
3.
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
by Elmarakby, Ahmed A.
Cardiovascular therapeutics, 2012-02, Vol.30 (1), p.49-59
4.
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients
by Shah, Lokesh
Pediatric nephrology (Berlin, West), 2019-06-27, Vol.34 (11), p.2343-2350
5.
Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts
by Menn-Josephy, Hanni
American journal of nephrology, 2016-10, Vol.44 (4), p.289-299
6.
Hemodialysis vascular access and subsequent transplantation: a report from the ESPN/ERA-EDTA Registry
by Boehm, Michael
Pediatric nephrology (Berlin, West), 2019, Vol.34 (4), p.713-721
7.
Acquired cystic kidney disease: an under-recognized condition in children with end-stage renal disease
by Chan, Eugene Y. H
Pediatric nephrology (Berlin, West), 2017-04-25, Vol.33 (1), p.41-51
8.
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study
by Aitken, Emma
Pain medicine (Malden, Mass.), 2017-02-01, Vol.18 (2), p.330-340
9.
Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study
by Li, S.-Y
Clinical microbiology and infection, 2011-11, Vol.17 (11), p.1646-1652
10.
Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease
by Lee, Timmy
American journal of nephrology, 2016-06, Vol.43 (5), p.334-340
11.
A Population-Based Assessment of the Familial Component of Chronic Kidney Disease Mortality
by Goldfarb-Rumyantzev, Alexander S
American journal of nephrology, 2006-05, Vol.26 (2), p.142-148
12.
Antihypertensive Medication Exposure and Cardiovascular Outcomes in Hemodialysis Patients
by Shireman, Theresa I
American journal of nephrology, 2014-09, Vol.40 (2), p.113-122
13.
Fabry's disease: Case series and review of literature
by Wani, Muzaffar
Annals of medical and health sciences research, 2016-07-01, Vol.6 (3), p.193-197
14.
Global trends in diabetes complications: a review of current evidence
by Harding, Jessica L
Diabetologia, 2018-08-31, Vol.62 (1), p.3-16
15.
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans
by Chretien, J-P
Journal of medical genetics, 2006-12, Vol.43 (12), p.917-923
16.
Epidemiology of chronic kidney disease in children
by Harambat, Jérôme
Pediatric nephrology (Berlin, West), 2012, Vol.27 (3), p.363-373
17.
Advances in the treatment of diabetic renal disease: focus on losartan
by Rayner, Brian
Current Medical Research and Opinion, 2004-05, Vol.20 (3), p.333-340
18.
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease
by Lees, Jennifer S
Nature medicine, 2019-11, Vol.25 (11), p.1753-1760
19.
Management of patients at risk of acute kidney injury
by Vanmassenhove, Jill, MD
The Lancet (British edition), 2017, Vol.389 (10084), p.2139-2151
20.
Gut microbiome and kidney disease: a bidirectional relationship
by Al Khodor, Souhaila
Pediatric Nephrology, 2016-04-29, Vol.32 (6), p.921-931
